The CRISPR-Cas adaptive immune system defends microbes against foreign genetic elements via DNA or RNA-DNA interference. We characterize the Class 2 type VI-A CRISPR-Cas effector C2c2 and demonstrate its RNA-guided RNase function. C2c2 from the bacterium Leptotrichia shahii provides interference against RNA phage. In vitro biochemical analysis show that C2c2 is guided by a single crRNA and can be programmed to cleave ssRNA targets carrying complementary protospacers. In bacteria, C2c2 can be programmed to knock down specific mRNAs. Cleavage is mediated by catalytic residues in the two conserved HEPN domains, mutations in which generate catalytically inactive RNA-binding proteins. These results broaden our understanding of CRISPR-Cas systems and suggest that C2c2 can be used to develop new RNA-targeting tools.
3 composite active site (Kim et al., 2013; Niewoehner and Jinek, 2016; Sheppard et al., 2016) , but C2c2 contains two HEPN domains, suggesting that it functions as a monomeric endoribonuclease.
As is common with Class 2 systems, type VI systems are simply organized. In particular, the type VI locus in Leptotrichia shahii contains Cas1, Cas2, C2c2 and a CRISPR array, which is expressed and processed into mature crRNAs (Shmakov et al., 2015) . In all CRISPR-Cas systems characterized to date, Cas1 and Cas2 are exclusively involved in spacer acquisition (Datsenko et al., 2012; Diez-Villasenor et al., 2013; Heler et al., 2015a; Nunez et al., 2014; Nunez et al., 2015; Yosef et al., 2012) , suggesting that C2c2 is the sole effector protein which utilizes a crRNA guide to achieve interference, likely targeting RNA.
Reconstitution of the L. shahii C2c2 locus in Escherichia coli confers RNA-guided immunity
We explored whether LshC2c2 could confer immunity to MS2 (Tamulaitis et al., 2014) , a lytic single-stranded (ss) RNA phage, without DNA intermediates in its life cycle, that infects E. coli.
We constructed a low-copy plasmid carrying the entire LshC2c2 locus (pLshC2c2) to allow for heterologous reconstitution in E. coli ( Figure S1A ). Because expressed mature crRNAs from the LshC2c2 locus have a maximum spacer length of 28nt ( Figure S1A ) (Shmakov et al., 2015) , we tiled all possible 28-nt target sites in the MS2 phage genome ( Figure 1A) . This resulted in a library of 3,473 spacer sequences (along with 588 non-targeting guides designed to have a Levenshtein distance of ≥8 with respect to the MS2 and E. coli genomes) which we inserted between pLshC2c2 direct repeats (DRs). After transformation in of this construct into E. coli, we infected cells with varying dilutions of MS2 (10 -1 , 10 -3 , and 10 -5 ) and analyzed surviving cells to determine the spacer sequences carried by cells that survived the infection. Cells carrying spacers that confer robust interference against MS2 are expected to proliferate faster than those that lack such sequences. Following growth for 16 hours, we identified a number of spacers that were consistently enriched across three independent infection replicas in both the 10 -1 and 10 -3 dilution conditions, suggesting that they enabled interference against MS2. Specifically, 152 and 144 spacers showed >0.8 log 2fold enrichment in all three replicates for the 10 -1 and 10 -3 phage dilutions, respectively; of these two groups of top enriched spacers, 75 are shared (Figs. 1B, S2A-G, table S1). Additionally, no non-targeting guides were found to be consistently enriched among the three 10 -1 , 10 -3 , or 10 -5 phage replicates (Figure S2D, G) . We also analyzed the flanking regions of protospacers on the 4 MS2 genome corresponding to the enriched spacers and found that spacers with a G immediately flanking the 3' end of the protospacer were less fit relative to all other nucleotides at this position (i.e. A, U, or C), suggesting that the 3ʹ protospacer flanking site (PFS) affects the efficacy of C2c2mediated targeting (Figs. 1C, S2E-F, S3 ). Although the PFS is adjacent to the protospacer target, we chose not to use the commonly used protospacer adjacent motif (PAM) nomenclature as it has come to connote a sequence used in self vs. non-self differentiation (Marraffini and Sontheimer, 2010) , which is irrelevant in a RNA-targeting system. It is worth noting that the avoidance of G by C2c2 echo the absence of PAMs applicable to other RNA-targeting CRISPR systems and effector proteins (Hale et al., 2014; Hale et al., 2012; Samai et al., 2015; Staals et al., 2014; Tamulaitis et al., 2014; Zhang et al., 2012) .
The fact that only ~5% of crRNAs are enriched may reflect other factors influencing interference activity, such as accessibility of the target site that might be affected by RNA binding proteins or secondary structure. In agreement with this hypothesis, the enriched spacers tend to cluster into regions of strong interference where they are closer to each other than one would expect by random chance ( Figure S3F -G).
To validate the interference activity of the enriched spacers, we individually cloned four topenriched spacers into pLshC2c2 CRISPR arrays and observed a 3-to 4-log 10 reduction in plaque formation, consistent with the level of enrichment observed in the screen (Figs 1B, S4) . We cloned sixteen guides targeting distinct regions of the MS2 mat gene (4 guides per possible singlenucleotide PFS). All 16 crRNAs mediated MS2 interference, although higher levels of resistance were observed for the C, A, and U PFS-targeting guides (Figs. 1D, 1E, S5), indicating that C2c2 can be effectively retargeted in a crRNA-dependent fashion to sites within the MS2 genome.
To further validate the observed PFS preference with an alternate approach, we designed a protospacer site in the pUC19 plasmid at the 5' end of the ß-lactamase mRNA, which encodes ampicillin resistance in E. coli, flanked by five randomized nucleotides at the 3' end. Significant depletion and enrichment was observed for the LshC2c2 locus (****, p<0.0001) compared to the pACYC184 controls ( Figure S6A ). Analysis of the depleted PFS sequences confirmed the presence of a PFS preference of H ( Figure S6B ).
C2c2 is a single-effector endoRNase mediating ssRNA cleavage with a single crRNA guide
We purified the LshC2c2 protein ( Figure S7 ) and assayed its ability to cleave an in vitro transcribed 173-nt ssRNA target ( Figs. 2A, S8 ) containing a C PFS (ssRNA target 1 with protospacer 14).
Mature LshC2c2 crRNAs contain a 28-nt direct repeat (DR) and a 28 nt spacer ( Figure S1A ) (Shmakov et al., 2015) . We therefore generated an in-vitro-transcribed crRNA with a 28-nt spacer complementary to protospacer 14 on ssRNA target 1. LshC2c2 efficiently cleaved ssRNA in a Mg 2+ -and crRNA-dependent manner (Figs. 2B, S9). We then annealed complementary RNA oligos to regions flanking the crRNA target site. This partially double-stranded RNA substrate was not cleaved by LshC2c2, suggesting it is specific for ssRNA (figs. S10A-B).
We tested the sequence constraints of RNA cleavage by LshC2c2 with additional crRNAs complementary to ssRNA target 1 where protospacer 14 is preceded by each PFS variant. The results of this experiment confirmed the preference for C, A, and U PFSs, with little cleavage activity detected for the G PFS target ( Figure 2C ). Additionally, we designed 5 crRNAs for each possible PFS (20 total) across the ssRNA target 1 and evaluated cleavage activity for LshC2c2 paired with each of these crRNAs. As expected, we observed less cleavage activity for G PFStargeting crRNAs compared to other crRNAs tested ( Figure 2D ).
We then generated a dsDNA plasmid library with protospacer 14 flanked by 7 random nucleotides to account for any PFS preference. When incubated with LshC2c2 protein and a crRNA complementary to protospacer 14, no cleavage of the dsDNA plasmid library was observed ( Figure   S10C ). We also did not observe cleavage when targeting a ssDNA version of ssRNA target 1 ( Figure S10D ). To rule out co-transcriptional DNA cleavage, which has been observed in type III CRISPR-Cas systems (Samai et al., 2015) , we recapitulated the E. coli RNA polymerase cotranscriptional cleavage assay (Samai et al., 2015) ( Figure S11A ) expressing ssRNA target 1 from a DNA substrate. This assay of purified LshC2c2 and crRNA targeting ssRNA target 1 did not show any DNA cleavage ( Figure S11B ). Together, these results indicate that C2c2 cleaves specific ssRNA sites directed by the target complementarity encoded in the crRNA, with a H PFS preference.
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C2c2 cleavage depends on local target sequence and secondary structure
Given that C2c2 did not efficiently cleave dsRNA substrates and that ssRNA can form complex secondary structures, we reasoned that cleavage by C2c2 might be affected by secondary structure of the ssRNA target. Indeed, after tiling ssRNA target 1 with different crRNAs ( Figure 2D ), we observed the same cleavage pattern regardless of the crRNA position along the target RNA. This observation suggests that the crRNA-dependent cleavage pattern was determined by features of the target sequence rather than the distance from the binding site. We hypothesized that the LshC2c2-crRNA complex binds the target and cleaves exposed regions of ssRNA within the secondary structure elements, with potential preference for certain nucleotides.
In agreement with this hypothesis, cleavage of three ssRNA targets with different sequences flanking identical 28-nt protospacers resulted in three distinct patterns of cleavage ( Figure 3A ).
RNA-sequencing of the cleavage products for the three targets revealed that cleavage sites mainly localized to uracil-rich regions of ssRNA or ssRNA-dsRNA junctions within the in silico predicted co-folds of the target sequence with the crRNA (Figs. 3B-C, S12A-D). To test whether the LshC2c2-crRNA complex prefers cleavage at uracils, we analyzed the cleavage efficiencies of homopolymeric RNA targets (a 28-nt protospacer extended with 120 As or Us regularly interspaced by single bases of G or C to enable oligo synthesis) and found that LshC2c2 preferentially cleaved the uracil target compared to adenine (figs. S12E, S12F). We then tested cleavage of a modified version of ssRNA 4 which had its main site of cleavage, a loop, replaced with each of the four possible homopolymers and found that cleavage only occurred at the uracil homopolymer loop ( Figure S12G ). To further test whether cleavage was occurring at uracil residues, we mutated single uracil residues in ssRNA 1 that showed cleavage in the RNAsequencing ( Figure 3B ) to adenines. This experiment showed that, by mutating each uracil residue, we could modulate the presence of a single cleavage band, consistent with LshC2c2 cleaving at uracil residues in ssRNA regions ( Figure 3D ).
The HEPN domains of C2c2 mediate RNA-guided ssRNA-cleavage
Bioinformatic analysis of C2c2 has suggested that the HEPN domains are likely to be responsible for the observed catalytic activity (Shmakov et al., 2015) . Each of the two HEPN domains of C2c2 contains a dyad of conserved arginine and histidine residues ( Figure 4A ), in agreement with the 7 catalytic mechanism of the HEPN endoRNAse (Anantharaman et al., 2013; Niewoehner and Jinek, 2016; Sheppard et al., 2016) . We mutated each of these putative catalytic residues separately to alanine (R597A, H602A, R1278A, H1283A) in the LshC2c2 locus plasmids and assayed for MS2 interference. None of the four mutant plasmids were able to protect E. coli from phage infection (Figs. 4B, S13).
We purified the four single-point mutant proteins and assayed their ability to cleave 5'-end-labeled ssRNA target 1 ( Figure 4C ). In agreement with our in vivo results, all four mutations abolished cleavage activity. The inability of either of the two wild-type HEPN domains to compensate for inactivation of the other implies cooperation between the two domains. These results agree with observations that several bacterial and eukaryotic single-HEPN proteins function as dimers (Kozlov et al., 2011; Niewoehner and Jinek, 2016; Sheppard et al., 2016) .
Catalytically inactive variants of Cas9 retain target DNA binding, allowing for the creation of programmable DNA-binding proteins (Gasiunas et al., 2012; Jinek et al., 2012) . Electrophoretic mobility shift assays (EMSA) on both the wild-type ( Figure 4D ) and R1278A mutant LshC2c2 ( Figure 4E ) in complex with crRNA showed the wild-type LshC2c2 complex binding strongly (K D ~ 46 nM, Figure S14A ) and specifically to 5'-end-labeled ssRNA target 10 but not to the 5'-endlabeled non-target ssRNA (the reverse complement of ssRNA target 10). The R1278A mutant C2c2 complex showed even stronger (K D ~ 7 nM, Figure S14B ) specific binding, indicating that this HEPN mutation results in a catalytically inactive, RNA-programmable RNA-binding protein.
The LshC2c2 protein or crRNA alone showed reduced levels of target affinity, as expected ( Figure   S14C -E). Additionally, no specific binding of LshC2c2-crRNA complex to ssDNA was observed ( Figure S15 ).
These results demonstrate that C2c2 cleaves RNA via a catalytic mechanism distinct from other known CRISPR-associated RNases. In particular, the type III Csm and Cmr multiprotein complexes rely on acidic residues of RRM domains for catalysis, whereas C2c2 achieves RNA cleavage through the conserved basic residues of its two HEPN domains.
Sequence and structural requirements of C2c2 crRNA
Similar to the type V-B (Cpf1) systems (Zetsche et al., 2015) , the LshC2c2 crRNA contains a single stem loop in the direct repeat (DR), suggesting that the secondary structure of the crRNA could facilitate interaction with LshC2c2. We thus investigated the length requirements of the spacer sequence for ssRNA cleavage and found that LshC2c2 requires spacers of at least 22 nt length to efficiently cleave ssRNA target 1 ( Figure S16A ). The stem-loop structure of the crRNA is also critical for ssRNA cleavage, because DR truncations that disturbed the stem loop abrogated target cleavage ( Figure S16B ). Thus, a DR longer than 24 nt is required to maintain the stem loop necessary for LshC2c2 to mediate ssRNA cleavage.
Single base pair inversions in the stem that preserved the stem structure did not affect the activity of the LshC2c2 complex. In contrast, inverting all four G-C pairs in the stem eliminated the cleavage despite maintaining the duplex structure ( Figure S17A ). Other perturbations, such as those that introduced kinks and reduced or increased base-pairing in the stem, also eliminated or drastically suppressed cleavage. This suggests that the crRNA stem length is important for complex formation and activity ( Figure S17A ). We also found that loop deletions eliminated cleavage, whereas insertions and substitutions mostly maintained some level of cleavage activity ( Figure S17B ). In contrast, nearly all substitutions or deletions in the region 3' to the DR prevented cleavage by LshC2c2 ( fig S18) . Together, these results demonstrate that LshC2c2 recognizes structural characteristics of its cognate crRNA but is amenable to loop insertions and most tested base substitutions outside of the 3' DR region. These results have implications for the future application of C2c2-based tools that require guide engineering for recruitment of effectors or modulation of activity (Dahlman et al., 2015; Kiani et al., 2015; Konermann et al., 2015) .
C2c2 cleavage is sensitive to double mismatches in the crRNA-target duplex
We tested the sensitivity of the LshC2c2 system to single mismatches between the crRNA guide and target RNA by mutating single bases across the spacer to the respective complementary bases (e.g., A to U). We then quantified plaque formation with these mismatched spacers in the MS2 infection assay and found that C2c2 was fully tolerant to single mismatches across the spacer as such mismatched spacers interfered with phage propagation with similar efficiency as fully matched spacers (figs. S19A, S20). However, when we introduced consecutive double substitutions in the spacer, we found a ~3 log 10 -fold reduction in the protection for mismatches in 9 the center, but not at the 5'-or 3'-end, of the crRNA (figs. 19B, S20). This observation suggests the presence of a mismatch-sensitive "seed region" in the center of the crRNA-target duplex.
We generated a set of in vitro transcribed crRNAs with mismatches similarly positioned across the spacer region. When incubated with LshC2c2 protein, all single mismatched crRNA supported cleavage ( Figure S19C ), in agreement with our in vivo findings. When tested with a set of consecutive and non-consecutive double mutant crRNAs, LshC2c2 was unable to cleave the target RNA if the mismatches were positioned in the center, but not at the 5'-or 3'-end of the crRNA ( Figure S19D, S21A) , further supporting the existence of a central seed region. Additionally, no cleavage activity was observed with crRNAs containing consecutive triple mismatches in the seed region ( Figure S21B ).
C2c2 can be reprogrammed to mediate specific mRNA knockdown in vivo
Given the ability of C2c2 to cleave target ssRNA in a crRNA sequence-specific manner, we tested whether LshC2c2 could be reprogrammed to degrade selected non-phage ssRNA targets, and particularly mRNAs, in vivo. We co-transformed E. coli with a plasmid encoding LshC2c2 and a crRNA targeting the mRNA of red fluorescent protein (RFP) as well as a compatible plasmid expressing RFP ( Figure 5A ). For OD-matched samples, we observed an approximately 20% to 92% decrease in RFP positive cells for crRNAs targeting protospacers flanked by C, A, or U PFSs ( Figure 5B , C). As a control, we tested crRNAs containing reverse complements (targeting the dsDNA plasmid) of the top performing RFP mRNA-targeting spacers. As expected, we observed no decrease in RFP fluorescence by these crRNAs ( Figure 5B ). We also confirmed that mutation of the catalytic arginine residues in either HEPN domain to alanine precluded RFP knockdown ( Figure S22 ). Thus, C2c2 is capable of general retargeting to arbitrary ssRNA substrates, governed exclusively by predictable nucleic-acid interactions.
When we examined the growth of cells carrying the RFP-targeting spacer with the greatest level of RFP knockdown, we noted that the growth rate of these bacteria was substantially reduced ( Figure 5A, spacer 7) . We investigated whether the effect on growth was mediated by the RFP mRNA-targeting activity of LshC2c2 by introducing an inducible-RFP plasmid and an RFPtargeting LshC2c2 locus into E. coli. Upon induction of RFP transcription, cells with RFP knockdown showed substantial growth suppression, not observed in non-targeting controls ( Figure   5D , E). This growth restriction was dependent on the level of the RFP mRNA, as controlled by the concentration of the inducer anhydrotetracycline. In contrast, in the absence of RFP transcription, we did not observe any growth restriction nor did we observe any transcription-dependent DNA targeting in our biochemical experiment ( Figure S11) . These results indicate that RNA-targeting is likely the primary driver of this growth restriction phenotype. We therefore surmised that, in addition to the cleavage of the target RNA, C2c2 CRISPR systems might prevent virus reproduction also via non-specific cleavage of cellular mRNAs, causing programmed cell death (PCD) or dormancy (Hayes and Van Melderen, 2011; Makarova et al., 2009 ).
C2c2 cleaves collateral RNA in addition to crRNA-targeted ssRNA
Cas9 and Cpf1 cleave DNA within the crRNA-target heteroduplex at defined positions, reverting to an inactive state after cleavage. In contrast, C2c2 cleaves the target RNA outside of the crRNA binding site at varying distances depending on the flanking sequence, presumably within exposed ssRNA loop regions (Figs. 3B, 3C , S12A-D). This observed flexibility with respect to the cleavage distance led us to test whether cleavage of other, non-target ssRNAs also occurs upon C2c2 target binding and activation. Under this model, the C2c2-crRNA complex, once activated by binding to its target RNA, cleaves the target RNA as well as other RNAs non-specifically. We carried out in vitro cleavage reactions that included, in addition to LshC2c2 protein, crRNA and its target RNA, one of four unrelated RNA molecules without any complementarity to the crRNA guide ( Figure   6A ). These experiments showed that, whereas the LshC2c2-crRNA complex did not mediate cleavage of any of the four collateral RNAs in the absence of the target RNA, all four were efficiently degraded in the presence of the target RNA (Figs. 6B, S23A ). Furthermore, R597A and R1278A HEPN mutants were unable to cleave collateral RNA ( Figure S23B ).
To further investigate the collateral cleavage and growth restriction in vivo, we hypothesized that if a PFS preference screen for LshC2c2 was performed in a transcribed region on the transformed plasmid, then we should be able to detect the PFS preference due to growth restriction induced by RNA targeting. We designed a protospacer site flanked by five randomized nucleotides at the 3' end in either a non-transcribed region or in a region transcribed from the lac promoter ( Figure   S24A ). The analysis of the depleted and enriched PFS sequences identified a H PFS only in the 11 assay with the transcribed sequence but no discernable motif in the non-transcribed sequence ( Figure S24B-C) .
These results suggest a HEPN-dependent mechanism whereby C2c2 in a complex with crRNA is activated upon binding to target RNA and subsequently cleaves non-specifically other available ssRNA targets. Such promiscuous RNA cleavage could cause cellular toxicity, resulting in the observed growth rate inhibition. These findings imply that, in addition to their likely role in direct suppression of RNA viruses, type VI CRISPR-Cas systems could function as mediators of a distinct variety of PCD or dormancy induction that is specifically triggered by cognate invader genomes (Figure 7) . Under this scenario, dormancy would slow the infection and supply additional time for adaptive immunity. Such a mechanism agrees with the previously proposed coupling of adaptive immunity and PCD during the CRISPR-Cas defensive response (Makarova et al., 2012) .
Conclusions
In summary, the Class 2 type VI effector protein C2c2 is an RNA-guided RNase that can be efficiently programmed to degrade any ssRNA by specifying a 28-nt sequence on the crRNA ( Figure 10 ). C2c2 cleaves RNA through conserved basic residues within its two HEPN domains, in contrast to the catalytic mechanisms of other known RNases found in CRISPR-Cas systems (Benda et al., 2014; Tamulaitis et al., 2014) . Alanine substitution of any of the four predicted HEPN domain catalytic residues converted C2c2 into an inactive programmable RNA-binding protein (dC2c2, analogous to dCas9). Many different spacer sequences work well in our assays although further screening will likely define properties and rules governing optimal function.
These results suggest a broad range of biotechnology applications and research questions (Abil and Zhao, 2015; Filipovska and Rackham, 2011; Mackay et al., 2011) . For example, the ability of dC2c2 to bind to specified sequences could be used to (i) bring effector modules to specific transcripts to modulate their function or translation, which could be used for large-scale screening, construction of synthetic regulatory circuits and other purposes; (ii) fluorescently tag specific RNAs to visualize their trafficking and/or localization; (iii) alter RNA localization through domains with affinity for specific subcellular compartments; and (iv) capture specific transcripts (through direct pull down of dC2c2) to enrich for proximal molecular partners, including RNAs and proteins.
Active C2c2 also has many potential applications such as targeting a specific transcript for destruction, as performed here with RFP. In addition, C2c2, once primed by the cognate target, can cleave other (non-complementary) RNA molecules in vitro and inhibit cell growth in vivo.
Biologically, this promiscuous RNase activity might reflect a PCD/dormancy-based protection mechanism of the type VI CRISPR-Cas systems (Figure 7) . Technologically, it might be used to trigger PCD or dormancy in specific cells such as cancer cells expressing a particular transcript, neurons of a given class, or cells infected by a specific pathogen.
Further experimental study is required to elucidate the mechanisms by which the C2c2 system acquires spacers and the classes of pathogens against which it protects bacteria. The presence of the conserved CRISPR adaptation module consisting of typical Cas1 and Cas2 proteins in the LshC2c2 locus suggests that it is capable of spacer acquisition. Although C2c2 systems lack reverse transcriptases, which mediate acquisition of RNA spacers in some type III systems (Silas et al., 2016) , it is possible that additional host or viral factors could support RNA spacer acquisition. Additionally or alternatively, type VI systems could acquire DNA spacers similar to other CRISPR-Cas variants but then target transcripts of the respective DNA genomes, eliciting PCD and abortive infection (Figure 7) .
The CRISPR-C2c2 system represent a distinct evolutionary path among Class 2 CRISPR-Cas systems. It is likely that other, broadly analogous Class 2 RNA-targeting immune systems exist, and further characterization of the diverse members of Class 2 systems will provide a deeper understanding of bacterial immunity and provide a rich starting point for the development of programmable molecular tools for in vivo RNA manipulation.
Materials and Methods
Expanded materials and methods, including computational analysis, can be found in supplementary materials and methods.
Bacterial phage interference
The C2c2 CRISPR locus was amplified from DNA from Leptotrichia shahii DSM 19757 (ATCC, Manassas, VA) and cloned for heterologous expression in E. coli. For screens, a library of all possible spacers targeting the MS2 genome were cloned into the spacer array; for individual spacers, single specific spacers were cloned into the array. Interference screens were performed in liquid culture and plated; surviving colonies were harvested for DNA and spacer representation was determined by next-generation sequencing. Individual spacers were tested by spotting on top agar.
β-lactamase and transcribed/non-transcribed PFS preference screens
Sequences with randomized nucleotides adjacent to protospacer 1 were cloned into pUC19 in corresponding regions. Libraries were screened by co-transformation with LshC2c2 locus plasmid or pACYC184 plasmid control, harvesting of the surviving colonies, and next-generation sequencing of the resulting regions.
RFP targeting assay
Cells containing an RFP expressing plasmid were transformed with an LshC2c2 locus plasmid with corresponding spacers, grown overnight, and analyzed for RFP fluorescence by flow cytometry. The growth effects of LshC2c2 activity were quantified by titrating inducible RFP levels with dilutions of anhydrotetracycline inducer and then measuring OD 600 . in vitro nuclease and electrophoretic mobility shift assays.
LshC2c2 protein and HEPN mutants were purified for use in in vitro reactions; RNA were synthesized via in vitro transcription. For nuclease assays, protein was co-incubated with crRNA and either 3' or 5'-labeled targets and analyzed via denaturing gel electrophoresis and imaging or by next-generation sequencing. For electrophoretic mobility shift assays, protein and nucleic acid were co-incubated and then resolved by gel electrophoresis and imaging. B) The cleavage sites of non-homopolymer ssRNA target 1 were mapped with RNAsequencing of the cleavage products. The frequency of cleavage at each base is colored according to the z-score and shown on the predicted crRNA-ssRNA co-fold secondary structure. Fragments used to generate the frequency analysis contained the complete 5' end. The 5' and 3' end of the ssRNA target are indicated by blue and red outlines, on the ssRNA and secondary structure, respectively. The 5' and 3' end of the spacer (outlined in 21 yellow) is indicated by the blue and orange residues highlighted respectively. The crRNA nucleotides are highlighted in orange. C) Plot of the frequencies of cleavage sites for each position of ssRNA target 1 for all reads that begin at the 5' end. The protospacer is indicated by the blue highlighted region. Step 1: crRNA library design
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